Global Thin Film Drugs Market Growth (Status and Outlook) 2023-2029

Global Thin Film Drugs Market Growth (Status and Outlook) 2023-2029

Thin-film drug delivery uses a dissolving film or oral drug strip to administer drugs via absorption in the mouth and/or via the small intestines. A film is prepared using hydrophilic polymers that rapidly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made.
LPI (LP Information)' newest research report, the “Thin Film Drugs Industry Forecast” looks at past sales and reviews total world Thin Film Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Thin Film Drugs sales for 2023 through 2029. With Thin Film Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Thin Film Drugs industry.
This Insight Report provides a comprehensive analysis of the global Thin Film Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Thin Film Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Thin Film Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Thin Film Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Thin Film Drugs.
The global Thin Film Drugs market size is projected to grow from US$ 7541.3 million in 2022 to US$ 14180 million in 2029; it is expected to grow at a CAGR of 9.4% from 2023 to 2029.
Global Thin Film Drugs key players include GSK, LTS, J&J, Indivior, Pfizer, etc. Global top five manufacturers hold a share over 35%.
Europe is the largest market, with a share about 40%, followed by Asia-Pacific, and North America, both have a share about 45 percent.
In terms of product, Transdermal Film is the largest segment, with a share over 70%. And in terms of application, the largest application is Drugstores, followed by Hospitals, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of Thin Film Drugs market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Transdermal Film
Oral Thin Film
Others
Segmentation by application
Hospitals
Drugstores
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GSK
LTS
J&J
Indivior
Pfizer
Sanofi
Church & Dwight
tesa Labtec
Tapemark
Prestige Bands
Sun Pharma
MonoSol
BioDelivery
Arx
ZIM
NAL Pharma
AdhexPharma
Aavishkar
IntelGenx Corp
APR

Please note: The report will take approximately 2 business days to prepare and deliver.